Regular monitoring of thyroid function is essential for patients with Hashimoto's thyroiditis who commence GLP-1 receptor agonist therapy
Healing protocols may show accelerated progress, with users reporting faster resolution of injuries compared to previous experiences
These findings point towards a stratified, phenotype-based treatment approach
Conclusion MetS is not classified as a disease per se but rather as a cluster of metabolic risk factors that have the potential to substantially elevate the likelihood of developing CVD
However, severe pain, swelling that lasts more than 3 days, signs of infection (warmth, redness, pus), or numbness around the injection site warrant immediate contact with your PlexusDx care team
It is approved for both adults and children aged 12 and older who have obesity